Fig. 5.
Activity of vWF-cleaving protease and the level of its inhibitor in comparison with the platelet count during 400 days of observation. The inhibitor assays were performed after 10 minutes of preincubation of patient plasma (PP) and NHP at three different ratios (4:1, 1:1, and 1:5 vol/vol).